TEM Likuiditas cepet Tempus

Tempus AI, Inc (TEM) offers a crisis-resistant genomic analysis service with insurance-covered services. The platform's digital architecture ensures instantaneous data scaling for physicians. The company's innovations focus on multimodal AI models in oncology. The warehouse-free liquidity ratio demonstrates the business's solvency, with the indicator value standing at 3.25.

Operational flexibility of digital supply chains is critical for Tempus AI, Inc (TEM), which integrates genomic data via AI. This quick ratio assesses the company's ability to instantaneously settle obligations without liquidating tangible assets. The calculation is based on the ratio of cash and accounts receivable to current liabilities. A decline in this coefficient signals rising financial risks and a potential loss of solvency.